Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer.

Hata K, Goto Y, Hashimoto M, Takahashi Y, Takiguchi Y, Saito S, Iwamoto Y, Enei Y, Sakanaka K, Hisakane A, Yamazaki T, Urabe F, Yanagisawa T, Tsuzuki S, Shimomura T, Kimura T, Tojo T, Kobayashi H

Open source

DOI
10.1155/aiu/2359934
Published
2026
Container
Advances in urology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/aiu/2359934,
  title = {Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer.},
  author = {Hata K and Goto Y and Hashimoto M and Takahashi Y and Takiguchi Y and Saito S and Iwamoto Y and Enei Y and Sakanaka K and Hisakane A and Yamazaki T and Urabe F and Yanagisawa T and Tsuzuki S and Shimomura T and Kimura T and Tojo T and Kobayashi H},
  year = {2026},
  journal = {Advances in urology},
  doi = {10.1155/aiu/2359934},
  url = {https://doi.org/10.1155/aiu/2359934}
}

RIS

TY  - JOUR
TI  - Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer.
AU  - Hata K
AU  - Goto Y
AU  - Hashimoto M
AU  - Takahashi Y
AU  - Takiguchi Y
AU  - Saito S
AU  - Iwamoto Y
AU  - Enei Y
AU  - Sakanaka K
AU  - Hisakane A
AU  - Yamazaki T
AU  - Urabe F
AU  - Yanagisawa T
AU  - Tsuzuki S
AU  - Shimomura T
AU  - Kimura T
AU  - Tojo T
AU  - Kobayashi H
PY  - 2026
JO  - Advances in urology
DO  - 10.1155/aiu/2359934
UR  - https://doi.org/10.1155/aiu/2359934
ER  - 

APA

K, H., Y, G., M, H., Y, T., Y, T., S, S., Y, I., Y, E., K, S., A, H., T, Y., F, U., T, Y., S, T., T, S., T, K., T, T., & H, K. (2026). Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer.. Advances in urology. https://doi.org/10.1155/aiu/2359934

Source records